A key result from the profiling study showed that exosomal EpCAM and CD24 levels were significantly higher in ovarian cancer patient samples, and pairing these protein profiles increased diagnostic accuracy to 97% for distinguishing cancer from non-cancer controls. The gene discussed is CD24; the disease is cancer.